Themis Medicare’s anti-viral COVID drug gets DCGI nod

Mumbai-based pharmaceutical company Themis Medicare’s anti-viral drug Viralex has received Drugs Controller General of India’s (DCGI) approval, the company informed the stock exchange on Monday.